Not Tagged
Not Tagged
['gi ']
recurring theme in today s #asco23 gi cancer session is that in multiple gi cancer types pathologic response to upfront drug therapy is not correlating with improved survival. we can t be cavalier in using it as a definitive sign of success without os improvements.
Physician-Scientist/Clinical Cancer Biologist. Clinical focus: GI Cancers/Neuro-Oncology. In lab: #TunnelingNanotubes and other drivers of La ChemoResistance